1. Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S. COG Acute Myeloid Leukemia Committee. Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia. Pediatr Blood Cancer. 2013; 60:964–971. PMID:
23255301.
Article
2. Horibe K, Saito AM, Takimoto T, et al. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology. Int J Hematol. 2013; 98:74–88. PMID:
23702913.
Article
3. Park HJ, Moon EK, Yoon JY, et al. Incidence and survival of childhood cancer in Korea. Cancer Res Treat. 2016; 48:869–882. PMID:
26790965.
Article
4. Kömür M, Erbey F, Bayram I, Tanyeli A. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia. Asian Pac J Cancer Prev. 2010; 11:1393–1395. PMID:
21198299.
5. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998; 92:2322–2333. PMID:
9746770.
6. Kim G, Lee HO, Choi JS, Baek HJ, Kook H. Characteristics and therapeutic outcomes of acute promyelocytic leukemia in children and adolescents. Clin Pediatr Hematol Oncol. 2016; 23:105–115.
Article
7. ter Bals E, Kaspers GJ. Treatment of childhood acute myeloid leukemia. Expert Rev Anticancer Ther. 2005; 5:917–929. PMID:
16221060.
Article
8. Gupta V. Alternative donor transplants for high-risk acute myeloid leukemia. Curr Opin Hematol. 2008; 15:115–120. PMID:
18300757.
Article
9. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64:83–103. PMID:
24488779.
Article
10. Dama E, Pastore G, Mosso ML, et al. Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Pediatr. 2006; 165:240–249. PMID:
16411094.
Article
11. Kang KS, Park JH, Lee JT, Lee KB. Survival rates of acute leukemia patients by FAB classification. Korean J Hematol. 1992; 27:239–247.
12. Lee DH, Chung NG, Cho B, et al. Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea. J Korean Med Sci. 2010; 25:9–15. PMID:
20052341.
Article
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985; 103:620–625. PMID:
3862359.
15. O'Donnell MR, Abboud CN, Altman J, et al. NCCN Clinical Practice Guidelines acute myeloid leukemia. J Natl Compr Canc Netw. 2012; 10:984–1021. PMID:
22878824.
16. Burnett AK, Wheatley K, Goldstone AH, et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol. 2002; 118:385–400. PMID:
12139722.
Article
18. Park EH, Lee H, Won YJ, et al. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012. Blood Res. 2015; 50:204–217. PMID:
26770948.
Article
19. Hjalgrim LL, Rostgaard K, Schmiegelow K, et al. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst. 2003; 95:1539–1544. PMID:
14559876.
Article
20. Viana MB, Cunha KC, Ramos G, Murao M. Acute myeloid leukemia in childhood: 15-year experience in a single institution. J Pediatr (Rio J). 2003; 79:489–496. PMID:
14685445.
21. Imamura T, Iwamoto S, Kanai R, et al. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study. Br J Haematol. 2012; 159:204–210. PMID:
22924344.
Article
22. Creutzig U, Zimmermann M, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005; 19:2030–2042. PMID:
16304570.
Article
23. Klein K, Kaspers G, Harrison CJ, et al. Clinical impact of additional cytogenetic aberrations, cKIT and ras mutations, and treatment elements in pediatric t(8;21)-AML: results from an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group. J Clin Oncol. 2015; 33:4247–4258. PMID:
26573082.
Article
24. Park HS, Kim DW, Kim CC, et al. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study. Semin Hematol. 1996; 33(4 Suppl 3):24–29.
25. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001; 97:56–62. PMID:
11133742.
26. Gupta V, Tallman MS, He W, et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010; 116:1839–1848. PMID:
20538804.
Article
27. Zheng C, Zhu X, Tang B, et al. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia. Ann Hematol. 2015; 94:473–480. PMID:
25217231.
Article
28. Xu XJ, Tang YM, Song H, Yang SL, Shi SW, Wei J. Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China. Leuk Lymphoma. 2010; 51:2262–2269. PMID:
20929322.
Article
29. Wiangnon S, Veerakul G, Nuchprayoon I, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011; 12:2215–2220. PMID:
22296359.
30. Chow EJ, Puumala SE, Mueller BA, et al. Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer. 2010; 116:3045–3053. PMID:
20564410.